Tianlin Wang

No.28 Fuxing Road
Haidian, 100853, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Application of artificial intelligence in geriatric infection: recent advances and prospects.

Application of artificial intelligence in geriatric infection: recent advances and prospects.

Journal: Frontiers in cellular and infection microbiology

Published: May 21, 2026

Xiao Xu Ming Decoction attenuates cerebral ischemia-reperfusion injury by promoting remyelination and reducing white matter injury.

Xiao Xu Ming Decoction attenuates cerebral ischemia-reperfusion injury by promoting remyelination and reducing white matter injury.

Journal: Journal of ethnopharmacology

Published: March 19, 2026

M2 microglial exosomal miR-1949 ameliorates sepsis-associated encephalopathy through DKK1/Wnt/β-catenin-mediated microglial repolarization.

M2 microglial exosomal miR-1949 ameliorates sepsis-associated encephalopathy through DKK1/Wnt/β-catenin-mediated microglial repolarization.

Journal: Archives of pharmacal research

Published: November 07, 2025

Patient Version of Guideline for Fibromyalgia (2025 Edition).

Patient Version of Guideline for Fibromyalgia (2025 Edition).

Journal: Journal of evidence-based medicine

Published: June 17, 2025

Incidence, clinical characteristics and related drugs analyzing of drug-induced movement disorders in 102914 inpatients: a retrospective real-world study.

Incidence, clinical characteristics and related drugs analyzing of drug-induced movement disorders in 102914 inpatients: a retrospective real-world study.

Journal: Expert opinion on drug safety

Published: April 26, 2025

Clinical prediction of sodium valproate-induced movement disorders in hospitalized patients: a nomogram-based model using real-world data.

Clinical prediction of sodium valproate-induced movement disorders in hospitalized patients: a nomogram-based model using real-world data.

Journal: International journal of clinical pharmacy

Published: April 18, 2025

Dl-3-n-butylphthalide reduces urokinase-induced hemorrhagic transformation after stroke by targeting NET-mediated microglial activation.

Dl-3-n-butylphthalide reduces urokinase-induced hemorrhagic transformation after stroke by targeting NET-mediated microglial activation.

Journal: Experimental neurology

Published: April 17, 2025

Chinese population may require further venetoclax dose reduction beyond guidelines when combined with voriconazole: real-world evidence from China.

Chinese population may require further venetoclax dose reduction beyond guidelines when combined with voriconazole: real-world evidence from China.

Journal: Frontiers in pharmacology

Published: December 04, 2024

Population pharmacokinetics of levetiracetam in Chinese adult epilepsy patients with varying renal function: exposure simulation and individualized dosing adjustments.

Population pharmacokinetics of levetiracetam in Chinese adult epilepsy patients with varying renal function: exposure simulation and individualized dosing adjustments.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: July 28, 2024

Biomarkers in the early stage of PD-1 inhibitor treatment have shown superior predictive capabilities for immune-related thyroid dysfunction.

Biomarkers in the early stage of PD-1 inhibitor treatment have shown superior predictive capabilities for immune-related thyroid dysfunction.

Journal: Frontiers in immunology

Published: July 02, 2024

Enhancing professional adaptability and clinical soft skills of new clinical pharmacists through a pre-training model in China: a randomized controlled trial.

Enhancing professional adaptability and clinical soft skills of new clinical pharmacists through a pre-training model in China: a randomized controlled trial.

Journal: BMC medical education

Published: May 30, 2024

Development of a physiologically based pharmacokinetic model for levetiracetam in patients with renal impairment to guide dose adjustment based on steady-state peak/trough concentrations.

Development of a physiologically based pharmacokinetic model for levetiracetam in patients with renal impairment to guide dose adjustment based on steady-state peak/trough concentrations.

Journal: Xenobiotica; the fate of foreign compounds in biological systems

Published: February 12, 2024

Showing 1-12 of 24

Last Updated: 09/26/2026